Search Results

Site Search

Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights

Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...

Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights

An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...

March 2023 - Hematopathology & Laboratory Genetics and Genomics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case's sub-specialties are Hematopathology and Laboratory Genetics and Genomics.

CPT Codes and LOINC Update: Feb. 2019 - Insights

View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of February 2019.

CPT codes and LOINC update: November 2022 - Insights

This list includes updates posted to mayocliniclabs.com during the month of November.

A Test in Focus Archives - Page 2 of 10 - Insights

Skip to Content MayoACCESS MayoLINK...

Respiratory disease - Insights

Learn about our suite of tests that are designed to detect a variety of respiratory viruses, including COVID-19, influenza, and RSV.

Bile acid malabsorption - Insights

Chronic diarrhea and abdominal pain can be caused by many conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Celiac disease, infectious GI pathogens, and malignancy. When other causes of chronic diarrhea...

A Test in Focus Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Pediatric CNS Disorder Testing - Mayo Clinic Laboratories

We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.